01 August 2012: Hypothesis
A novel hypothesis: The application of platelet-rich plasma can promote the clinical healing of white-white meniscal tears
Li-Cheng Wei ABE , Shu-Guang Gao ABE , Mai Xu CD , Wei Jiang CD , Jian Tian CD , Guang-Hua Lei EFG
DOI: 10.12659/MSM.883254
Med Sci Monit 2012; 18(8): HY47-50
Abstract
ABSTRACT: The white-white tears (meniscus lesion completely in the avascular zone) are without blood supply and theoretically cannot heal. Basal research has demonstrated that menisci are unquestionably important in load bearing, load redistribution, shock absorption, joint lubrication and the stabilization of the knee joint. It has been proven that partial or all-meniscusectomy results in an accelerated degeneration of cartilage and an increased rate of early osteoarthritis. Knee surgeons must face the difficult decision of removing or, if possible, retaining the meniscus; if it is possible to retain the meniscus, surgeons must address the difficulties of meniscal healing. Some preliminary approaches have progressed to improve meniscal healing. However, the problem of promoting meniscal healing in the avascular area has not yet been resolved. The demanding nature of the approach as well as its low utility and efficacy has impeded the progress of these enhancement techniques. Platelet-rich plasma (PRP) is a platelet concentration derived from autologous blood. In recent years, PRP has been used widely in preclinical and clinical applications for bone regeneration and wound healing. Therefore, we hypothesize that the application of platelet-rich plasma for white-white meniscal tears will be a simple and novel technique of high utility in knee surgery.
Keywords: Platelet-Rich Plasma - metabolism, Models, Biological, Menisci, Tibial - pathology, Knee Joint - pathology, Knee Injuries - therapy, Wound Healing
Background
White-white meniscal tear is a difficult problem, and obtaining satisfactory healing of meniscal tears continues to be a major clinical challenge, especially if the tear involves the inner avascular zone. Theoretically, a white-white meniscal tear (in the avascular area) will not heal after a suture repair alone. Trauma is one of the most common etiologies of meniscal tears. For example, 40% to 60% of patients who sustain a rupture of the anterior cruciate ligament also sustain a meniscal tear. Many of these tears extend into the middle-third avascular region. Poor long-term clinical results following partial and total meniscectomy have been reported [1]. It is amenable and important to repair meniscus lesions. However, repairing white-white meniscal tears remains an enigma. Many methods have sought to enhance the healing of white-white meniscal tears until they are provided healing potential (e.g., mechanical trephination, abrasion, exogenous fibrin clot, synovial flaps, high-frequency current, gluing, fascia sheath coverage and fibrin clot, meniscus wrap, technique growth factors, synthetic matrices, and stem cells). Most results are too preliminary to warrant speculation about their potential for clinical use. Some new techniques focus on meniscus tissue engineering such as cell-based therapy and gene therapy, tissue-engineered collagen meniscus implant, or the use of a degradable scaffold for meniscus regeneration. Studies [2,3] are being conducted to find the optimal method, but these have not yet been applied to humans. Thus the controversies about white-white meniscal tears have not ceased. Platelet-rich plasma (PRP) is defined as a biological product for platelet concentration, which is collected from centrifuged whole blood. Through the activation of a reactivator, the accumulated platelets can secrete a large quantity of a preparation rich in growth factors (PRGFs) via the release of intracellular granules. Simultaneously, PRP fragments can polymerize to platelet-rich gel (PRG), which consists of fibrin, fibronectin and vitronectin. In 1998, Dr Robert E. Marx [4] first proposed the use of PRP to enhance the initial phases of bone wound healing. Although the disputes about the increased prevalence of PRP therapy always exist, some authors [5] have claimed a theoretical basis for the prevalence. In the last few years, PRP has been applied as a means to facilitate the healing process in fields such as bone injuries [6–9], chondrogenesis [10], chondral defects [11], reduction of bone resorption [12], cruciate ligament repair [13,14], chronic elbow tendinosis [15], Achilles tendinopathy [16], rotator cuff repair [17,18], jumper’s knee [19], chronic soft lesion [20], cardiac disease [21], dentistry, and maxillofacial surgery [22]. Although some studies have shown that platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis can promote osteoarthritic cartilage healing, better results were achieved in younger patients with a low degree of cartilage degeneration [23–25]. So far, no studies have demonstrated that PRP can improve the clinical healing of white-white meniscal tears.
Evidence Supporting the Hypothesis for Healing of White-White Meniscal Tears
The effect of PRP was first introduced by Marx et al. in a 1998 study on bone regeneration for maxillofacial reconstructions. Since then many scholars [26–28] have paid close attention to PRP. Many animal and clinical research efforts have indicated that PRP can promote bone regeneration, wound healing, nerve repair, tendon repair, and burn healing. Some authors combined PRP with a scaffold to repair bone defects, with encouraging results [29]. Kitoh et al. [30] developed a new technique for the transplantation of culture-expanded bone marrow cells (BMC) and PRP in distraction osteogenesis of the long bones in humans. Filardo et al. [23] performed a 12-month follow-up study, and promising results were obtained using intra-articular PRP injections in treating patients with knee degeneration. Using a quantification of cell proliferation, as well as proteoglycan (PG) and collagen synthesis, Akeda et al. [31] reported that PRP isolated from autologous blood may be useful as a source of anabolic growth factors for stimulating chondrocytes to engineer cartilage tissue. Fresno et al. [32] demonstrated that PRP application appeared to increase granulation tissue and fibrosis in pigs, but did not influence anastomotic breaking strength. Kurita et al. [33] concluded that a controlled release system of PRP was effective in inducing angiogenesis for critical ischemia in randomized studies, and vascularization was enhanced in critical limb ischemia rats treated by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel. Some authors reported that platelet-rich plasma has a good effect on chondrogenic differentiation of human subchondral progenitor cells [34], and inhibition of inflammatory processes in osteoarthritic chondrocytes [35].
The majority of these studies suggest that the receptors of cytokines associated with PRGFs are widely localized on the surfaces of all types of human cells, including meniscus cells. After injury, high levels of these receptors are expressed in the lesion areas. Admittedly, the details of the mechanism involved remains to be clarified, but probably involves receptors on target cells, which in turn are thought to develop high-energy phosphate bonds to internal cytoplasmic signal proteins to initiate specific activity of PDGF, including mitogenesis (increase in the population of healing cells), angiogenesis (endothelial mitoses into functioning capillaries), and macrophage activation (debridement of the wound site and a second phase source of growth factors for continued repair and bone regeneration). How PRP affects human meniscus cells is not known. Notably, animal meniscus cells isolated from the white-on-white zone were cultured at various concentrations of PDGF-AB [36], showing that meniscal cells and, more importantly, cells from the avascular zone are capable of responding favorably to the addition of PDGF-AB. Following stimulation with this growth factor, these cells express their intrinsic potential to proliferate and generate new extracellular matrix.
Hypothesis
On the basis of the above analyses, we propose the hypothesis that PRP and its derivatives have great potential for the treatment of white-white meniscal tears as PRP may provide growth factors that enhance the healing of the meniscus through promoting meniscus cell proliferation and vascularization. We suggest that the mechanism is that activated platelets are a source of growth factors such as platelet-derived growth factor, transforming growth factor beta, fibroblast growth factor, and vascular endothelial growth factor (VEGF). Among them, insulin-like growth factor could regulate meniscus cell proliferation, VEGF could promote meniscus white-white area (avascular area) vascularization, and transforming growth factor beta could attract and activate several types of cells, such as fibroblasts or bone-marrow-derived stem cells in the surrounding tissues to differentiate meniscus cells. These growth factors could engage in a positive feedback during this interaction. PRP gel could be delivered arthroscopically to the avascular area tear after the routine protocol is followed. When PRP is activated to release PRGFs for white-white meniscal tears, PRP could also bridge the lesions as a tissue-engineering scaffold to reconstruct the meniscus. In 1936, King [37] stated that for a meniscal tear to heal, the torn meniscus must communicate with its peripheral blood supply. Therefore, the biggest obstruction to healing in a white-white meniscal tear is the avascular nature of the tissue. By promoting vascularization and cell proliferation, the slow healing and low efficacy of treatment of white-on-white meniscal tears may be solved through autograft PRP in clinical arthroscopy.
Evaluation and Discussion of the Hypothesis
Converging evidence from many areas supports a unifying hypothesis that the application of platelet-rich plasma can bring a breakthrough in the clinical puzzle, and promote the clinical healing of white-on-white meniscal tears. We can further explore the optimal concentration for a white-on-white meniscal tears. Long-term clinical follow-up and evaluation were completed through special physical examination, radiology review, MRI review and Lysholm Knee Scale scores. Meanwhile, the biomechanics changes between meniscus repaired by PRP and non-PRP application should be investigated by second arthroscopy.
PRP has been applied in clinical environments to repair peripheral nerve injury, oral-bone loss, injured tendons or ligaments, and dry eye symptoms, as well as to promote bone regeneration, articular chondrocyte healing, intestinal wound healing, and burn wounding healing. Despite the potential applications in the field of clinical research [38–41], the majority of PRP research has been performed in animal models [42–45]. As for PRP, it is low cost, convenient and does not induce any adverse reaction compared with other growth factors derived from gene-tissue engineering. In addition, the preparation of PRP is convenient, which is beneficial for applications in clinical practice.
However, there are still several issues in the clinical use of PRP. There is no standard regarding the optimal concentration of PRP with which to enhance healing. Moreover, the optimal concentrations for bone regeneration, peripheral nerve injury, articular chondrocyte healing and other domains, such as meniscus lesion, may be different. Few authors suggested that high concentrations of PRP could suppress cell proliferation
Conclusions
We propose that PRP could become a novel, high efficacy and convenient application for white-white meniscal tears in clinical practice. However, there are still unanswered questions, such as mechanism of action, and optimal concentration needs further investigation.
Reference
1. Arnoczky SP, McDevitt CA, The meniscus: structure, function, repair, and replacement: Orthopaedic Basic Science, 2000; 531-45, Rosemont, II, American Academy of Orthopaedic Surgeons
2. Dutton AQ, Choong PF, Goh JC, Enhancement of meniscal repair in the avascular zone using mesenchymal stem cells in a porcine model: J Bone Joint Surg Br, 2010; 92(1); 169-75, pmid: 20044699
3. Abdel-Hamid M, Hussein MR, Ahmad AF, Enhancement of the repair of meniscal wounds in the red-white zone (middle third) by the injection of bone marrow cells in canine animal model: Int J Exp Pathol, 2005; 86(2); 117-23, pmid: 15810983
4. Marx RE, Carlson ER, Eichstaedt RM, Platelet-rich plasma: Growth factor enhancement for bone grafts: Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998; 85(6); 638-46, pmid: 9638695
5. Plöderl K, Strasser C, Hennerbichler S, Development and validation of a production process of platelet lysate for autologous use: Platelets, 2011; 22(3); 204-9, pmid: 21158495
6. Kanthan SR, Kavitha G, Addi S, Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit models: Injury, 2011; 42(8); 782-89, pmid: 21329922
7. Latalski M, Elbatrawy YA, Thabet AM, Enhancing bone healing during distraction osteogenesis with platelet-rich plasma: Injury, 2011; 42(8); 821-24, pmid: 21513935
8. Weibrich G, Hansen T, Kleis W, Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration: Bone, 2004; 34; 665-71, pmid: 15050897
9. Jungbluth P, Wild M, Grassmann JP, Platelet-rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini-pigs: J Orthop Res, 2010; 28(11); 1448-55, pmid: 20872580
10. Wu CC, Chen WH, Zao B, Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis: Biomaterials, 2011; 32(25); 5847-54, pmid: 21616530
11. Milano G, Sanna Passino E, Deriu L, The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model: Osteoarthritis Cartilage, 2010; 18(7); 971-80, pmid: 20433936
12. Marukawa E, Oshina H, Iino G, Reduction of bone resorption by the application of platelet-rich plasma (PRP) in bone grafting of the alveolar cleft: J Craniomaxillofac Surg, 2011; 39(4); 278-83, pmid: 20542707
13. Spindler KP, Murray MM, Carey JL, The use of platelets to affect functional healing of an anterior cruciate ligament (ACL) autograft in a caprine ACL reconstruction model: J Orthop Res, 2009; 27; 631-38, pmid: 19009602
14. Fallouh L, Nakagawa K, Sasho T, Effects of autologous platelet-rich plasma on cell viability and collagen synthesis in injured human anterior cruciate ligament: J Bone Joint Surg Am, 2010; 92(18); 2909-16, pmid: 21159991
15. Mirsha A, Pavelko T, Treatment of chronic elbow tendinosis with buffered platelet-rich plasma: Am J Sports Med, 2006; 34; 1774-78, pmid: 16735582
16. Gaweda K, Tarczynska M, Krzyzanowski W, Treatment of Achilles tendinopathy with platelet-rich plasma: Int J Sports Med, 2010; 31; 577-83, pmid: 20535661
17. Randelli P, Arrigoni P, Ragone V, Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up: J Shoulder Elbow Surg, 2011; 20(4); 518-28, pmid: 21570659
18. Barber FA, Hrnack SA, Snyder SJ, Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation: Arthroscopy, 2011; 27(8); 1029-35, pmid: 21802625
19. Kon E, Filardo G, Delcogliano M, Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper’s knee: Injury, 2009; 40; 598-603, pmid: 19380129
20. Liu J, Yuan T, Zhang C, Three cases using platelet-rich plasma to cure chronic soft tissue lesions: Transfus Apher Sci, 2011; 45(2); 151-55, pmid: 21907002
21. Mishra A, Velotta J, Brinton TJ, RevaTen platelet-rich plasma improves cardiac function after myocardial injury: Cardiovasc Revasc Med, 2011; 12(3); 158-63, pmid: 21122486
22. Choi BH, Zhu SJ, Kim BY: Int J Oral Maxillofac Surg, 2005; 34; 420-24, pmid: 16053853
23. Filardo G, Kon E, Pereira Ruiz MT, Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach: Knee Surg Sports Traumatol Arthrosc, 2011; 19(4); 528-35, pmid: 20740273
24. Sánchez M, Guadilla J, Fiz N, Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip: Rheumatology (Oxford), 2012; 51(1); 144-50, pmid: 22075062
25. Kon E, Mandelbaum B, Buda R, Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis: Arthroscopy, 2011; 27(11); 1490-501, pmid: 21831567
26. Roldán JC, Jepsen S, Miller J: Bone, 2004; 34(1); 80-90, pmid: 14751565
27. Sarkar MR, Augat P, Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold: Biomaterials, 2006; 27(9); 1817-23, pmid: 16307796
28. Chang SH, Hsu YM, Wang YJ, Fabrication of pre-determined shape of bone segment with collagen-hydroxyapatite scaffold and autogenous platelet-rich plasma: J Mater Sci Mater Med, 2009; 20(1); 23-31, pmid: 18651114
29. Nair MB, Varma HK, Menon KV, Reconstruction of goat femur segmental defects using triphasic ceramic-coated hydroxyapatite in combination with autologous cells and platelet-rich plas: Acta Biomater, 2009; 5(5); 1742-55, pmid: 19297259
30. Kitoh H, Kitakoji T, Tsuchiya H, Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones: Bone, 2007; 40(2); 522-28, pmid: 17070744
31. Akeda K, An HS, Okuma M, Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis: Osteoarthritis Cartilage, 2006; 14(12); 1272-80, pmid: 16820306
32. Fresno L, Fondevila D, Bambo O, Effects of platelet-rich plasma on intestinal wound healing in pigs: Vet J, 2010; 185(3); 322-27, pmid: 19616459
33. Kurita J, Miyamoto M, Ishii Y, Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel: Ann Thorac Surg, 2011; 92(3); 837-44, pmid: 21871267
34. Krüger JP, Hondke S, Endres M, Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells: J Orthop Res, 2012; 30(6); 845-52, pmid: 22058056
35. Van Buul GM, Koevoet WL, Kops N, Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes: Am J Sports Med, 2011; 39(11); 2362-70, pmid: 21856929
36. Tumia NS, Johnstone AJ: Knee, 2009; 16(1); 73-76, pmid: 18976925
37. King D, The healing of the semilunar cartilage: J Bone Joint Surg Am, 1936; 18; 333
38. Merkx MA, Fennis JP, Verhagen CM, Reconstruction of the mandible using preshaped 2.3 mm titanium plates, autogenous particulate cortico-cancellous bone grafts and platelet rich plasma: a report on eight patients: Int J Oral Maxillofac Int J Oral Maxillofac Surg, 2004; 33(8); 733-39
39. Sampson S, Reed M, Silvers H, Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study: Am J Phys Med Rehabil, 2010; 89(12); 961-69, pmid: 21403592
40. Galasso O, Mariconda M, Romano G, Expandable intramedullary nailing and platelet rich plasma to treat long bone non-unions: J Orthop Traumatol, 2008; 9(3); 129-34, pmid: 19384608
41. Thor A, Franke-Stenport V, Johansson CB, Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results: Int J Oral Maxillofac Surg, 2007; 36(12); 1164-71, pmid: 17855054
42. Niemeyer P, Fechner K, Milz S, Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma: Biomaterials, 2010; 31(13); 3572-79, pmid: 20153047
43. Fennis JP, Stoelinga PJ, Jansen JA, Reconstruction of the mandible with an autogenous irradiated cortical scaffold, autogenous corticocancellous bone-graft and autogenous platelet-rich-plasma: an animal experiment: Int J Oral Maxillofac Surg, 2005; 34(2); 158-66, pmid: 15695045
44. Kroese-Deutman HC, Vehof JW, Spauwen PH, Orthotopic bone formation in titanium fiber mesh loaded with platelet-rich plasma and placed in segmental defects: Int J Oral Maxillofac Surg, 2008; 37(6); 542-49, pmid: 18325739
45. Hakimi M, Jungbluth P, Sager M, Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs: Injury, 2010; 41(7); 717-23, pmid: 20097341
46. Plachokova AS, van den Dolder J, van den Beucken JJ, Bone regenerative properties of rat, goat and human platelet-rich plasma: Int J Oral Maxillofac Surg, 2009; 38(8); 861-69, pmid: 19443180
47. Lee C, Nishihara K, Okawachi T, A quantitative radiological assessment of outcomes of autogenous bone graft combined with platelet-rich plasma in the alveolar cleft: Int J Oral Maxillofac Surg, 2009; 38(2); 117-25, pmid: 19147331
48. Casati MZ, de Vasconcelos Gurgel BC, Gonçalves PF, Platelet-rich plasma does not improve bone regeneration around peri-implant bone defects – A pilot study in dogs: Int J Oral Maxillofac Surg, 2007; 36(2); 132-36, pmid: 16890407
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387